SCHEMBL7892504

SCHEMBL7892504

CS(=O)(=O)Nc1ccc(C(=O)O)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 7/20 0.47
PKM P14618 1/20 0.43
LIG1 P18858 1/20 0.43
LMNA P02545 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
KEAP1 Q14145 1/20 0.39
CPT1A P50416 1/20 0.39
CPT1B Q92523 1/20 0.39
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1047927 0.83 DAO (0.44) DAOPKMLIG1LMNAPPARG
SCHEMBL17900428 0.77 NPSR1 (0.41) LMNAPPARGNCOA2NCOA1NPSR1
SCHEMBL28198399 0.76 DAO (0.54) DAOPKMLIG1KDM4EHSD17B10
SCHEMBL6735515 0.73 PKM (0.69) DAOPKMLIG1SMN1; SMN2HSD17B10
SCHEMBL16471204 0.72 DAO (0.48) DAOPKMLIG1KDM4EHPGD
SCHEMBL11630811 0.71 KIF11 (0.41) LMNAKEAP1KDM4ESMN1; SMN2HPGD
SCHEMBL322182 0.71 DAO (0.52) DAOPKMLIG1LMNAPPARG
SCHEMBL12368674 0.70 DAO (0.47) DAOPKMLIG1LMNAPPARG
SCHEMBL13155856 0.70 DAO (0.47) DAOPKMLIG1HSD17B10HPGD
SCHEMBL70493 0.70 DAO (0.67) DAOPKMLIG1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102574857-B Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors LEO PHARMA AS 2015-06-10 CN disclosed
US-6174883-B1 ENZYME INHIBITORS OF PROSTAGLANDIN H2 SYNTHASE, 5-LIPOXYGENASE; INHIBITORS OF INTERLEUKIN-1 BIOSYNTHESIS; ANALGESICS; ANTIINFLAMMATORY AND ANTIARTHRITIC AGENTS; BONE, CONNECTIVE TISSUE METABOLISM AND SKIN DISORDERS PFIZER INC. 2001-01-16 US disclosed
US-5919809-A 3-substituted-2-oxindole derivatives PFIZER INC. (US) 1999-07-06 US disclosed
EP-0393936-B1 3-substituted-2-oxindole derivatives as antiinflammatory agents PFIZER (US) 1995-02-22 EP disclosed
US-5300655-A 2-carboxy-thiophene derivatives PFIZER INC. (US) 1994-04-05 US disclosed
US-5290802-A 3-substituted-2-oxindole derivatives PFIZER INC. (US) 1994-03-01 US disclosed
US-5047554-A 3-substituted-2-oxindole derivatives PFIZER INC. (US) 1991-09-10 US disclosed
EP-0393936-A1 3-substituted-2-oxindole derivatives as antiinflammatory agents PFIZER INC. (US) 1990-10-24 EP disclosed